Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance-Reference-Cited by-同舟云学术

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

Published:2012-05 Issue:3 Volume:30 Page:301-305
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Guzzo Thomas J.,Resnick Matthew J.,Canter Daniel J.,Bivalacqua Trinity J.,Rosen Mark A.,Bergey Meredith R.,Magerfleisch Laurie,Tomazewski John E.,Wein Alan J.,Malkowicz S. Bruce

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference16 articles.

1. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring;Lilja;Nat Rev Cancer,2008

2. Prostate cancer: Epidemiology and health-related quality of life;Penson;Urology,2008

3. Lead times and overdetection due to prostate specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003

4. Prostate cancer: Indicators of aggressiveness;Sakr;Eur Urol,1997

5. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy;Han;Urol Clin North Am,2001

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of magnetic resonance imaging in active surveillance of prostate cancer;Radiologia Brasileira;2021-08

2. Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI;BMC Cancer;2018-11-01

3. Contemporary Epstein Criteria with Biopsy-Naïve Multiparametric Magnetic Resonance Imaging to Prevent Incorrect Assignment to Active Surveillance in the PI-RADS Version 2.0 Era;Annals of Surgical Oncology;2018-09-17

4. Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol;Urologia Internationalis;2018

5. Low-risk Prostate Cancer: Identification, Management, and Outcomes;European Urology;2017-08